Evaluation of Biochemical and Hematological Dynamics as Markers for Severe Dengue Forms

Authors

  • Manahil Irshad Student, 4Department of pharmacy, Yusra Institute of Pharmacy Yusra, Science, Rawalpindi
  • Anayat Sattar Student, Department of pharmacy, Yusra Institute of Pharmacy Yusra, Science, Rawalpindi
  • Izza Nadeem Student, Department of pharmacy, Yusra Institute of Pharmacy Yusra, Science, Rawalpindi
  • Irshad Sharjeel Ishfaq Student, Department of pharmacy, Yusra Institute of Pharmacy Yusra, Science, Rawalpindi

DOI:

https://doi.org/10.37506/hkb03455

Keywords:

dengue fever, hematological parameter, biochemical parameters

Abstract

Dengue is a viral infection that has become a serious problem in recent years. It is a major cause of mortality and morbidity. The present study is a prospective, hospital-based, observational study done from 2015 to October 2022. The objective of our study was to consider whether dengue infection can be suspected based on hematological and biochemical findings. The study included 100 patients positive for dengue infection. Complete haemograms, transaminases for liver injury, blood urea, and serum creatinine levels for renal assessment were performed for these patients. The most common hematological findings were thrombocytopenia, leucopenia, an increase in the mixed cell fraction of the leucocytes, and the presence of reactive lymphocytes. Biochemical parameters like aminotransferases, blood urea, and serum creatinine levels were significantly raised. Hence, a platelet count of <100,000 cells/μl, leucopenia of < 4000 cells/μl, and aspartate aminotransferase levels of >82.2 U/L can be considered predictors of dengue infection

Downloads

Download data is not yet available.

References

Guzman MG, Harris E. Dengue. Lancet (London, England). 2015 Jan 31;385(9966):453-65.doi:10.1016/s0140-6736(14)60572-9

Kularatne SAM, Weerakoon KGAD, Munasinghe R, Ralapanawa UK, Pathirage M. Trends of fluid requirement in dengue fever and dengue haemorrhagic fever: a single centre experience in Sri Lanka. BMC Res Notes. 2015 Apr 8;8(1):130. doi:10.1186/s13104-015-1085-0

Murugesan A, Manoharan M. Dengue virus. In: Emerging and Reemerging Viral Pathogens.Elsevier; 2020. p. 281-359.

Dieng I, dos Passos Cunha M, Diagne MM, et al. Origin and spread of the dengue virus type 1, genotype V in Senegal, 2015–2019. 2021;13(1):57.

Kuno G, Chang G-JJ, Tsuchiya KR, Karabatsos N, Cropp CBJJov. Phylogeny of the genus Flavivirus. 1998;72(1):73-83.

Camilo G, Alfonso C, Salim M, et al. Ecoepidemiology of Alphaviruses and Flaviviruses. 2020:101-125. doi:https://doi.org/10.1016/B978-0-12-819400-3.00006-5b

Paixão ES, Teixeira MG, Rodrigues LC. Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases. BMJ global health. 2018;3(Suppl 1):e000530. doi:10.1136/bmjgh-2017-000530

Dengue and severe dengue. World Health Organization. [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue

Simo FBN, Bigna JJ, Kenmoe S, et al. Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies. Sci Rep. 2019 Sep 20;9(1):13626. doi:10.1038/s41598-019-50135-x

Lee IK, Hsieh CJ, Lee CT, Liu JW. Diabetic patients suffering dengue are at risk for development of dengue shock syndrome/severe dengue: Emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity. J Microbiol Immunol Infect. 2020 Feb;53(1):69-78. doi:10.1016/j.jmii.2017.12.005

Figueiredo MAA, Rodrigues LC, Barreto ML, et al. Allergies and Diabetes as Risk Factors for Dengue Hemorrhagic Fever: Results of a Case Control Study. PLOS Neglected Tropical Diseases. 2010;4(6):e699. doi:10.1371/journal.pntd.0000699

Mahmood S, Hafeez S, Nabeel H, Zahra U, Nazeer H. Does Comorbidity Increase the Risk of Dengue Hemorrhagic Fever and Dengue Shock Syndrome? ISRN Tropical Medicine. 2013 Aug 20;2013:139273. doi:10.1155/2013/139273

Lien CE, Chou YJ, Shen YJ, Tsai T, Huang N. A Population-Based Cohort Study on Chronic Comorbidity Risk Factors for Adverse Dengue Outcomes. Am J Trop Med Hyg. 2021 Sep 27;105(6):1544-1551. doi:10.4269/ajtmh.21-0716

Chen CY, Lee MY, Lin KD, et al. Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. Int J Mol Sci. 2015 Feb 10;16(2):3820-30. doi:10.3390/ijms16023820

Pang J, Hsu JP, Yeo TW, Leo YS, Lye DC. Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study. Sci Rep. 2017 Jan 3;7:39872. doi:10.1038/srep39872

Mandal1 RK, DHT, DGKS, DKK, Chandraul4, DHS. Dengue Fever. Int J Res Pub Rev. 2022. Available from: https://ijrpr.com/uploads/V3ISSUE7/IJRPR5884.pdf

Waterman SH, Gubler DJ. Dengue fever. Clin Dermatol. 1989;7(1):117-122. doi:https://doi.org/10.1016/0738-081X(89)90034-5

Toledo J, George L, Martinez E, et al. Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review. PLOS Neglected Tropical Diseases. 2016;10(1):e0004284. doi:10.1371/journal.pntd.0004284

Downloads

Published

2024-05-22

How to Cite

Evaluation of Biochemical and Hematological Dynamics as Markers for Severe Dengue Forms. (2024). International Journal of Contemporary Pathology, 10(1), 7-17. https://doi.org/10.37506/hkb03455